1,353
Participants
Start Date
November 11, 2024
Primary Completion Date
July 15, 2025
Study Completion Date
July 15, 2025
Investigational Influenza Vaccine
Investigational Influenza Vaccine
COVID-19 Vaccine
Pfizer-BioNTech COVID-19 Vaccine
Influenza and COVID Combination Vaccine
Combined investigational influenza and Pfizer-BioNTech COVID-19 Vaccine
Licensed Influenza Vaccine 1
Licensed Influenza Vaccine 1
Licensed Influenza Vaccine 2
Licensed Influenza Vaccine 2
Placebo
Saline
Charlottesville Medical Research, Charlottesville
Clinical Research Atlanta, Stockbridge
Headlands Research Orlando, Orlando
Indago Research & Health Center, Inc, Hialeah
Palm Springs Community Health Center, Miami Lakes
Miami Dade Medical Research Institute, LLC, Miami
Clinical Research Professionals, Chesterfield
Bio-Kinetic Clinical Applications, LLC dba QPS-MO, Springfield
Bio-Kinetic Clinical Applications, LLC dba QPS-MO-Screening and Recruitment Center, Springfield
Velocity Clinical Research, Omaha, Omaha
SMS Clinical Research, Mesquite
DM Clinical Research- Cyfair, Houston
Dynamed Clinical Research, LP d/b/a DM Clinical Research, Tomball
J. Lewis Research, Inc. / Foothill Family Clinic, Salt Lake City
J. Lewis Research, Inc. / Foothill Family Clinic South, Salt Lake City
Las Vegas Clinical Trials, Las Vegas
Artemis Institute for Clinical Research, San Diego
Orange County Research Center, Lake Forest
Diablo Clinical Research, Inc., Walnut Creek
East-West Medical Research Institute, Honolulu
Clinical Research Consulting, Milford
ActivMed Practices & Research, LLC., Portsmouth
Lead Sponsor
Collaborators (1)
Pfizer
INDUSTRY
BioNTech SE
INDUSTRY